Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for ENOV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2008. Start Trial.
Date Value
June 30, 2026 75.03M
March 31, 2026 23.95M
December 31, 2025 88.54M
September 30, 2025 82.58M
June 30, 2025 47.77M
March 31, 2025 -1.596M
December 31, 2024 88.33M
September 30, 2024 53.56M
June 30, 2024 7.773M
March 31, 2024 -36.16M
December 31, 2023 68.42M
September 30, 2023 31.01M
June 30, 2023 28.10M
March 31, 2023 7.457M
December 31, 2022 -35.96M
September 30, 2022 19.41M
June 30, 2022 -24.89M
March 31, 2022 -14.42M
December 31, 2021 96.22M
September 30, 2021 97.13M
June 30, 2021 78.37M
March 31, 2021 84.38M
December 31, 2020 128.80M
September 30, 2020 79.92M
June 30, 2020 36.98M
Date Value
March 31, 2020 56.23M
December 31, 2019 65.20M
September 30, 2019 55.32M
June 30, 2019 82.72M
March 31, 2019 -72.29M
December 31, 2018 125.56M
September 30, 2018 67.15M
June 30, 2018 36.32M
March 31, 2018 -2.657M
December 31, 2017 104.08M
September 30, 2017 16.13M
June 30, 2017 58.15M
March 31, 2017 40.40M
December 31, 2016 145.12M
September 30, 2016 45.44M
June 30, 2016 40.90M
March 31, 2016 15.52M
December 31, 2015 151.68M
September 30, 2015 85.27M
June 30, 2015 68.92M
March 31, 2015 -2.05M
December 31, 2014 184.24M
September 30, 2014 162.06M
June 30, 2014 106.49M
March 31, 2014 -67.04M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Intuitive Surgical, Inc. 1.061B
STAAR Surgical Co. 19.69M
Zimmer Biomet Holdings, Inc. 447.80M
Inspire Medical Systems, Inc. 23.23M
Edwards Lifesciences Corp. 651.90M